Recruiting
Phase 1
Phase 2

ARV-766

Sponsor:

Novartis Pharmaceuticals

Code:

NCT05067140

Conditions

Prostate Cancer Metastatic

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ARV-766 Part A&B

ARV-766 + Abiraterone Part C&D

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information